The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach

PLoS One. 2021 Jul 14;16(7):e0254456. doi: 10.1371/journal.pone.0254456. eCollection 2021.

Abstract

Introduction: Vaccination programs aim to control the COVID-19 pandemic. However, the relative impacts of vaccine coverage, effectiveness, and capacity in the context of nonpharmaceutical interventions such as mask use and physical distancing on the spread of SARS-CoV-2 are unclear. Our objective was to examine the impact of vaccination on the control of SARS-CoV-2 using our previously developed agent-based simulation model.

Methods: We applied our agent-based model to replicate COVID-19-related events in 1) Dane County, Wisconsin; 2) Milwaukee metropolitan area, Wisconsin; 3) New York City (NYC). We evaluated the impact of vaccination considering the proportion of the population vaccinated, probability that a vaccinated individual gains immunity, vaccination capacity, and adherence to nonpharmaceutical interventions. We estimated the timing of pandemic control, defined as the date after which only a small number of new cases occur.

Results: The timing of pandemic control depends highly on vaccination coverage, effectiveness, and adherence to nonpharmaceutical interventions. In Dane County and Milwaukee, if 50% of the population is vaccinated with a daily vaccination capacity of 0.25% of the population, vaccine effectiveness of 90%, and the adherence to nonpharmaceutical interventions is 60%, controlled spread could be achieved by June 2021 versus October 2021 in Dane County and November 2021 in Milwaukee without vaccine.

Discussion: In controlling the spread of SARS-CoV-2, the impact of vaccination varies widely depending not only on effectiveness and coverage, but also concurrent adherence to nonpharmaceutical interventions.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / therapeutic use*
  • Computer Simulation
  • Humans
  • Masks
  • Patient Compliance / statistics & numerical data*
  • Physical Distancing
  • Respiratory Protective Devices / statistics & numerical data
  • United States
  • Urban Health
  • Vaccination Coverage / statistics & numerical data*

Substances

  • COVID-19 Vaccines